Letter to the Editor
Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy

https://doi.org/10.1016/j.jtho.2020.04.015Get rights and content
Under a Creative Commons license
open access

Abstract

The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patients with lung cancer and concomitant severe acute respiratory syndrome–coronavirus-2 infection.

Keywords

COVID-19
Lung cancer
IL-17 target therapy
Monoclonal antibody

Cited by (0)

Disclosure: The author declares no conflict of interest.

© 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc.